Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 9/2022

21-10-2021 | Morbus Osgood-Schlatter | Arthroscopy and Sports Medicine

Hyperosmolar dextrose injection for Osgood–Schlatter disease: a double-blind, randomized controlled trial

Authors: Zhe Wu, Xiaoxian Tu, Zhiyuan Tu

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 9/2022

Login to get access

Abstract

Objective

Osgood–Schlatter disease (OSD) is one of the common causes of long-term knee pain, leading to functional limitations, long-term deformity of the tubercle interfering with kneeling, and impaired peer-important sport participation. Nonetheless, patient management continues to rely on the usual conservative methods. This study examined the use of hyperosmolar dextrose injection in patients with OSD.

Methods

We conducted a randomized, double-blind clinical trial involving 70 patients with OSD. One group received a hyperosmolar dextrose injection (12.5%), while the other received a saline injection. The injections were conducted under ultrasound guidance. The Victorian Institute of Sport Assessment (VISA) score was used to assess each patient's pain and sport level.

Results

The dextrose group outperformed the saline group in improvement in the VISA-Patella (VISA-P) score from baseline to 3 months (27.1 ± 6.5 vs. 1.4 ± 2.6; mean difference 25.4 (22.4 to 28.3); p < .0001), 6 months (31.7 ± 7.9 vs. 25.2 ± 7.8; mean difference 6.2 (3.2 to 9.4); p < .0001), and 12 months (34 ± 9.0 vs. 28.2 ± 7.5; mean difference 5.5 (1.9 to 9.1); p = .0026). The changes in both groups were clinically important, suggesting that both therapies were active treatments. The dextrose group improved too rapidly for spontaneous improvement to explain much of this change.

Conclusion

After three injections, at the 6-month and 12-month follow-up visits, the VISA-P scores of the two groups were significantly improved; the dextrose group score was better than the saline group score, and there were significant differences between the two groups.
Literature
2.
3.
go back to reference Osgood RB (1993) Lesions of the tibial tubercle occurring during adolescence. 1903. Clin Orthop Relat Res 286:4–9CrossRef Osgood RB (1993) Lesions of the tibial tubercle occurring during adolescence. 1903. Clin Orthop Relat Res 286:4–9CrossRef
5.
go back to reference Md R, D V, (2003) Disability levels of college-aged men with a history of Osgood-Schlatter disease. J Strength Cond Res 17(4):659–663 Md R, D V, (2003) Disability levels of college-aged men with a history of Osgood-Schlatter disease. J Strength Cond Res 17(4):659–663
22.
go back to reference Hauser R, Hauser M, Baird N (2011) Evidence-based use of dextrose prolotherapy for musculoskeletal pain: A scientific literature review. J Prolotherapy 3(4):765–789 Hauser R, Hauser M, Baird N (2011) Evidence-based use of dextrose prolotherapy for musculoskeletal pain: A scientific literature review. J Prolotherapy 3(4):765–789
Metadata
Title
Hyperosmolar dextrose injection for Osgood–Schlatter disease: a double-blind, randomized controlled trial
Authors
Zhe Wu
Xiaoxian Tu
Zhiyuan Tu
Publication date
21-10-2021
Publisher
Springer Berlin Heidelberg
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 9/2022
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-021-04223-1

Other articles of this Issue 9/2022

Archives of Orthopaedic and Trauma Surgery 9/2022 Go to the issue